1,095 results on '"Tapson, Victor F."'
Search Results
52. Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
53. Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension
54. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
55. Lung Transplantation and Atrial Septostomy in Pulmonary Arterial Hypertension
56. One-year experience with intravenous treprostinil for pulmonary arterial hypertension
57. Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study): A Randomized Controlled Trial
58. Contemporary Trends in the Diagnosis and Management of Pulmonary Arterial Hypertension: An Initiative to Close the Care Gap
59. Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study): A Randomized Controlled Trial
60. Incidence of Thrombocytopenia among Patients Receiving Heparin Venous Thromboembolism Prophylaxis
61. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension
62. Risque thromboembolique veineux et pratique de prévention hospitalière : résultats obtenus en France de l’étude internationale ENDORSE
63. Factors at Admission Associated With Bleeding Risk in Medical Patients: Findings From the IMPROVE Investigators
64. Massive Pulmonary Embolism: Extracorporeal Membrane Oxygenation and Surgical Pulmonary Embolectomy: Controversies and Evolving Concepts in Deep Venous Thrombosis and Pulmonary Embolism
65. Catheter-Based Approaches for the Treatment of Acute Pulmonary Embolism: Controversies and Evolving Concepts in Deep Venous Thrombosis and Pulmonary Embolism
66. Controversies and Evolving Concepts in Acute Pulmonary Embolism: Controversies and Evolving Concepts in Acute Pulmonary Embolism
67. Interventional Therapies for Venous Thromboembolism: Vena Caval Interruption, Surgical Embolectomy, and Catheter-Directed Interventions
68. Improving Practices in US Hospitals to Prevent Venous Thromboembolism: Lessons from ENDORSE
69. Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
70. Thrombolytic Therapy for Acute Pulmonary Embolism: A Critical Appraisal
71. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry
72. Diagnosis of Pulmonary Embolism in the Coronary Care Unit
73. The Pulmonary Circulation
74. Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
75. Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine
76. Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III
77. Prophylaxis for venous thromboembolism: guidelines translated for the clinician
78. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
79. What Will It Take to Initiate a Move Toward a More Aggressive Therapeutic Approach to Venous Thromboembolism?
80. Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III)
81. Impact and Role of Pulmonary Embolism Response Teams in Venous Thromboembolism Associated with Covid-19
82. Radiologic mimics of pulmonary embolism
83. Reply
84. Contributors
85. Pulmonary Embolism
86. Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients: Findings From the International Medical Prevention Registry on Venous Thromboembolism
87. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study
88. Creation of a Model Comparing 6-Minute Walk Test to Metabolic Equivalent in Evaluating Treatment Effects in Pulmonary Arterial Hypertension
89. Clinical Characteristics of Patients with Acute Pulmonary Embolism: Data from PIOPED II
90. Identification, Diagnosis and Treatment of Heparin-induced Thrombocytopenia and Thrombosis: A Registry of Prolonged Heparin Use and Thrombocytopenia among Hospitalized Patients with and without Cardiovascular Disease: The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry Steering Committee
91. Multidetector computed tomography for acute pulmonary embolism
92. The Diagnosis and Management of Acute Pulmonary Embolism in 2021: Evolving Strategies
93. Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia
94. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension
95. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use
96. Thrombolytic Therapy for Acute Pulmonary Embolism
97. The evaluation of suspected pulmonary embolism
98. Endothelin Receptor Antagonists for the Treatment of Pulmonary Arterial Hypertension
99. Contributors
100. Pulmonary Embolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.